HELP LINE:
844-775-2273

Financial
Assistance

Financial
Assistance

Understanding Your Coverage Icon

Understanding your coverage

  • Commercial or private health insurance is medical coverage provided by your employer or can include some plans purchased directly from health insurance exchange (HIX) or individual healthcare policies.
  • Governmental insurance plans, such as Medicare, Medicaid, and TRICARE, are state- and federally funded plans designed for those who are 65 years of age or older or those who have a disability or low income or members of the military.
  • Uninsured patients may also have options for financial assistance.

Patients who have commercial or private health insurance

If you have commercial or private health insurance, we may be able to help lower the costs of KIMMTRAK.

Out-of-pocket costs

An annual balance is available from the start, so you can use as much as you need to cover your KIMMTRAK out-of-pocket costs.*

To be eligible, you should:

  • Be 18+ years of age and a resident of the United States or Puerto Rico
  • Have a prescription for KIMMTRAK from your healthcare provider
  • Not have governmental insurance, such as Medicare, Medicaid, or TRICARE
  • * Subject to terms and conditions of the program. Click here to learn more or speak with your dedicated nurse case manager.

Patients who have governmental insurance

If you have governmental insurance such as Medicare, Medicaid, or TRICARE, call KIMMTRAK CONNECT® to get more information on foundations that may be able to help you pay your out-of-pocket costs for your medication.

These same foundations may offer support with the costs of treatment. Your dedicated nurse case manager can help connect you with the financial resources that best fit your unique situation.

Find financial support by contacting
KIMMTRAK CONNECT

844-775-CARE (844-775-2273)

Available Monday-Friday, 9 AM-7 PM (EST)
Additionally, someone is available to help you 24/7.

Patients who are uninsured or underinsured

If you do not have insurance or you do not have enough insurance, we will work to help you find other ways to afford your treatment. A dedicated nurse case manager will look for other available options for cost coverage. These may include state health insurance exchanges. State drug assistance programs may be an option as well.

As a patient, the most important thing to remember is that you are not in this alone. Your dedicated nurse case manager is here to talk you through your options.

Contact a dedicated nurse case manager to learn more.

Indication and Important Safety Information Including Boxed Warning

Usage

KIMMTRAK is a prescription medicine used to treat HLA-A*02:01-positive adults with uveal melanoma that cannot be removed by surgery or has spread.

Important Safety Information

What is the most important information I should know about KIMMTRAK?

KIMMTRAK can cause serious side effects that can be severe or life threatening and usually happen within the first three infusions, including:

  • Cytokine Release Syndrome (CRS). Symptoms of CRS may include:
    • fever
    • tiredness or weakness
    • vomiting
    • chills
    • nausea
    • low blood pressure
    • dizziness and light-headedness
    • headache
    • wheezing and trouble breathing
    • rash

Tell your healthcare provider right away if you get any of these symptoms. Your healthcare provider will check for these problems during treatment with KIMMTRAK. Your healthcare provider may temporarily stop or completely stop your treatment with KIMMTRAK if you have severe side effects.

See "KIMMTRAK can cause other serious side effects" for more information.

Before receiving KIMMTRAK, tell your healthcare provider about all of your medical conditions, including if you:

  • are pregnant or plan to become pregnant. KIMMTRAK may harm your unborn baby. Tell your healthcare provider if you become pregnant during treatment with KIMMTRAK. For females who are able to become pregnant: For females who are able to become pregnant:
    • Your healthcare provider should do a pregnancy test before you start treatment with KIMMTRAK.
    • Use an effective form of birth control during treatment with KIMMTRAK and for at least 1 week after the last dose of KIMMTRAK.
  • are breastfeeding or plan to breastfeed. It is not known if KIMMTRAK passes into your breast milk. Do not breastfeed during the treatment with KIMMTRAK and for at least 1 week after the last dose of KIMMTRAK.

Tell your healthcare provider about all medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

KIMMTRAK can cause other serious side effects, including:
  • Skin reactions. KIMMTRAK may cause skin reactions that require treatment. Tell your healthcare provider if you get symptoms of skin reactions—such as rash, itching, or skin swelling—that are severe and do not go away.
  • Abnormal liver blood tests. Your healthcare provider will do blood tests to check your liver before you start KIMMTRAK and during treatment with KIMMTRAK. Tell your healthcare provider if you get symptoms of liver problems such as right-sided abdominal pain or yellowing of the skin or eyes.
The most common side effects of KIMMTRAK include:
  • cytokine release syndrome (CRS)
  • rash
  • fever
  • itching
  • tiredness
  • nausea
  • chills
  • stomach pain
  • swelling
  • low blood pressure (symptoms may
    include dizziness or light-headedness)
  • dry skin
  • headache
  • vomiting
  • abnormal liver blood tests

These are not all the side effects possible with KIMMTRAK.

Call your healthcare provider for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088 (1-800-332-1088).

Please read the accompanying Patient Information Leaflet before you receive KIMMTRAK and discuss any questions you have with your healthcare provider.

Please see KIMMTRAK Patient Information.

Important Safety Information
Including Boxed Warning

What is the most important information I should know about KIMMTRAK?

KIMMTRAK can cause serious side effects that can be severe or life threatening and usually happen within the first three infusions, including Cytokine Release Syndrome (CRS).

Usage

KIMMTRAK is a prescription medicine used to treat HLA-A*02:01-positive adults with uveal melanoma that cannot be removed by surgery or has spread.

Important Safety Information Including
Boxed Warning

What is the most important information I should know about KIMMTRAK?

KIMMTRAK can cause serious side effects that can be severe or life threatening and usually happen within the first three infusions, including Cytokine Release Syndrome (CRS).